Impact of liver immaturity when investigating medicinal products intended for neonatal use

Current version

PDF iconConcept paper

Reference numberEMEA/CHMP/PEG/194605/05
Published20/07/2005
KeywordsNeonates, medicines, developmental pharmacology, drug metabolising enzymes, maturational changes, immaturity
DescriptionThis document describes the issues relating to the immature capacity of neonates for metabolising and eliminating drugs by the liver.


Related content


How useful was this page?

Add your rating